Sanyasi Pharmaceuticals Private Limited
About Sanyasi Pharmaceuticals Private Limited
Data last updated:
Sanyasi Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 03 February 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2003PTC118777.
The company has an authorised share capital of ₹55 Lakh and a paid-up capital of ₹52.54 Lakh. It is led by directors Lata Arora and Parnika.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R 304 First Floor Greater Kailash – 1, New Delhi, Delhi, India – 110048.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sanyasi Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressR 304 First Floor Greater Kailash – 1, New Delhi, Delhi, India – 110048
- IndustryReal Estate, Real Estate Leasing
To see the full contact details of Sanyasi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Sanyasi Pharmaceuticals are trade and real estate. In detail, this covers wholesale trading and real estate activities with own or leased property. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| L | Real Estate | L1 | Real estate activities with own or leased property |
Financials of Sanyasi Pharmaceuticals Private Limited
FY 2025 filings availableSanyasi Pharmaceuticals Private Limited reported revenue of ₹5,589 (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 30%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sanyasi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sanyasi Pharmaceuticals Private Limited
Sanyasi Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lata Arora Also directs: G K Mines Private Limited, Dextrous Constructors Private Limited, Akshat Verdhman Investments Limited and 2 more | Director | 15 Mar 2013 | 13 Years 7 Months | Current |
| Parnika Also directs: G K Mines Private Limited, Dextrous Constructors Private Limited, Akshat Verdhman Investments Limited and 2 more | Director | 23 Mar 2022 | 4 Years 7 Months | Current |
Shareholding
The shareholding of Sanyasi Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sanyasi Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sanyasi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanyasi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sanyasi Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sanyasi Pharmaceuticals Private Limited has 7 board changes on record since 2013: 2 appointments and 5 cessations. The latest: Parnika ceased to be Additional Director on 29 Sep 2022.
Frequently asked questions
Sanyasi Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 03 February 2003 (23+ years old) and is registered under CIN U24231DL2003PTC118777.
Sanyasi Pharmaceuticals has 2 current directors:
- Lata Arora - Director
- Parnika - Director
The latest financial statements of Sanyasi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Sanyasi Pharmaceuticals is U24231DL2003PTC118777. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanyasi Pharmaceuticals was incorporated on 03 February 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.
Parnika ceased to be Additional Director on 29 Sep 2022. Parnika was appointed as Director on 23 Mar 2022. Lata Arora ceased to be Additional Director on 30 Sep 2013. Sanyasi Pharmaceuticals has 7 board changes on record in total.
The registered office of Sanyasi Pharmaceuticals is at R 304 First Floor Greater Kailash – 1, New Delhi, Delhi, India – 110048.
Sanyasi Pharmaceuticals operates in the real estate industry, in the real estate leasing segment.
The compliance status of Sanyasi Pharmaceuticals is compliant as of 01 August 2026. The company is actively filing with the Registrar of Companies.
Sanyasi Pharmaceuticals can be reached at its registered office: R 304 First Floor Greater Kailash – 1, New Delhi, Delhi, India – 110048.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
